Key facts
- This page summarizes Christopher B. Ehrlich's Form 4 filing for eFFECTOR Therapeutics, Inc..
- 2 reported transactions and 0 derivative rows are listed below.
- Filing timestamp: 22 Feb 2022, 15:59.
Christopher B. Ehrlich - 14 Feb 2022 Form 4 Insider Report for eFFECTOR Therapeutics, Inc.
- Role
- Director
- Signature
- /s/ Michael Byrnes, Attorney-in-Fact for Christopher B. Ehrlich
- Issuer symbol
- N/A
- Transactions as of
- 14 Feb 2022
- Net transactions value
- +$13,200
- Form type
- 4
- Filing time
- 22 Feb 2022, 15:59:33 UTC
- Previous filing
- 10 Feb 2022
- Next filing
- 13 Jun 2022
- SEC
- View on sec.gov
Key filing fact
Christopher B. Ehrlich filed Form 4 for eFFECTOR Therapeutics, Inc. on 22 Feb 2022.
Change
- Previous filing in this sequence was filed on 10 Feb 2022.
- Current net transaction value: +$13,200.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
See Original Filing
Ownership activity is grounded in SEC Form 4 disclosures.
Transactions Table
EFTR
transaction
Common Stock
Purchase
- Transaction value
- $8,900
- Shares
- +2,000
- Change %
- +15%
- Price
- $4.45
- Shares after
- 15,000
- Date
- 14 Feb 2022
- Ownership
- Direct
- Footnotes
- F1
EFTR
transaction
Common Stock
Purchase
- Transaction value
- $4,300
- Shares
- +1,000
- Change %
- +6.7%
- Price
- $4.30
- Shares after
- 16,000
- Date
- 18 Feb 2022
- Ownership
- Direct
EFTR
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 142,168
- Date
- 14 Feb 2022
- Ownership
- By Locust Walk Partners LLC
- Footnotes
- F2
EFTR
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 1,034
- Date
- 14 Feb 2022
- Ownership
- By Locust Walk Partners LLC
- Footnotes
- F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses:
| Id | Content |
|---|---|
| F1 | The price reported in Column 4 is a weighted average price. These shares were purchased in two transactions at prices ranging from $4.40 to $4.50. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. |
| F2 | Represents shares held directly by the Sponsor, of which Locust Walk Partners LLC ("LWP") is a member. LWP has allocated these shares to the reporting person. |
| F3 | Represents shares held directly by the Sponsor, of which LWP is a member. LWP has allocated these shares to the reporting person's spouse. |